|
Market Closed -
OTC Markets
18:57:58 03/06/2026 +04
|
5-day change | 1st Jan Change | ||
| 0.1052 USD | -2.09% |
|
-18.25% | -87.61% |
| 08-14 | CASI Pharmaceuticals, Inc. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 08-14 | Casi Pharmaceuticals, Inc. Announces Management Changes | CI |
| Market Cap | 2.65M 2.28M 2.14M 1.95M 3.68M 253M 3.69M 25.38M 9.9M 128M 9.94M 9.72M 424M | P/E 2024 |
-1.11x | P/E 2025 | -0.33x |
|---|---|---|---|---|---|
| Enterprise Value | 24.5M 21.11M 19.8M 18.07M 34.04M 2.34B 34.15M 235M 91.63M 1.18B 91.99M 89.99M 3.92B | EV / Sales 2024 |
1.75x | EV / Sales 2025 | 1.9x |
| Free-Float |
53.62% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -2.09% | ||
| 1 week | -18.25% | ||
| Current month | -18.25% | ||
| 1 month | -24.13% | ||
| 3 months | -12.25% | ||
| 6 months | -54.04% | ||
| Current year | -87.61% |
| 1 week | 0.11 |  | 0.14 |
| 1 month | 0.11 | | 0.17 |
| Current year | 0.05 | | 1.2 |
| 1 year | 0.05 | | 2.5 |
| 3 years | 0.05 | | 8.48 |
| 5 years | 0.05 | | 17.4 |
| 10 years | 0.05 | | 88.92 |
| Manager | Title | Age | Since |
|---|---|---|---|
David Cory
CEO | Chief Executive Officer | 62 | 21/07/2025 |
Kun Qian
DFI | Director of Finance/CFO | 44 | 16/05/2025 |
Chun Hua Wang
COO | Chief Operating Officer | 54 | 01/01/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
Yue Wu
BRD | Director/Board Member | 62 | 01/04/2013 |
Zhen Bo Su
BRD | Director/Board Member | 50 | 21/03/2023 |
Thomas Folinsbee
BRD | Director/Board Member | 59 | 21/03/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 18/03/26 | Emerging Technology Partners LLC
| Other | Company | 1,097,341 | 7.0830% | |
| 18/03/26 | Panacea Venture
| Other | Company | 4,529,956 | 29.2393% | |
| 18/03/26 | Other | Chief Financial Officer | 75,000 | 0.4841% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.09% | -18.25% | -95.68% | -95.59% | 2.65M | |
| -0.13% | -6.44% | +60.47% | +112.05% | 1,047B | |
| +0.85% | -0.81% | +52.77% | +63.15% | 646B | |
| -1.03% | -3.58% | +22.87% | +73.29% | 451B | |
| -1.46% | -4.50% | +37.43% | +38.41% | 355B | |
| -0.72% | -2.89% | +21.86% | +36.79% | 291B | |
| -1.19% | -2.21% | +1.35% | +12.29% | 252B | |
| -1.05% | -1.57% | +51.40% | +68.55% | 234B | |
| +0.08% | -1.78% | -17.64% | -54.29% | 203B | |
| -2.14% | -0.30% | +29.42% | +89.10% | 181B | |
| Average | -0.90% | -2.41% | +16.43% | +34.37% | 365.93B | |
| Weighted average by Cap. | -0.48% | -3.46% | +38.66% | +65.51% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 28.54M 24.59M 23.06M 21.05M 39.65M 2.73B 39.77M 274M 107M 1.38B 107M 105M 4.57B | 20.71M 17.85M 16.73M 15.28M 28.78M 1.98B 28.87M 199M 77.46M 999M 77.76M 76.07M 3.31B |
| Net income | -39.26M -33.83M -31.72M -28.95M -54.54M -3.75B -54.72M -376M -147M -1.89B -147M -144M -6.28B | -48.06M -41.41M -38.83M -35.44M -66.77M -4.59B -66.98M -461M -180M -2.32B -180M -177M -7.69B |
| Net Debt | 6.05M 5.21M 4.89M 4.46M 8.41M 578M 8.43M 57.99M 22.63M 292M 22.71M 22.22M 968M | 21.85M 18.83M 17.66M 16.12M 30.36M 2.09B 30.46M 209M 81.73M 1.05B 82.05M 80.27M 3.5B |
Employees
214
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | $0.1288 | -4.59% | 1,688 |
| 27/08/26 | $0.1350 | +4.81% | 137 |
| 25/08/26 | $0.1288 | -7.20% | 125 |
| 24/08/26 | $0.1388 | +7.76% | 487 |
| 20/08/26 | $0.1288 | -.--% | 1,227 |
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CASIF Stock
Select your edition
All financial news and data tailored to specific country editions
